株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

骨成長刺激製品の世界市場の予測 〜2022年:製品 (各種装置・骨形成タンパク質・多血小板血漿)・用途・エンドユーザー別

Bone Growth Stimulator Market by Product (Device, Boner Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022

発行 MarketsandMarkets 商品コード 498752
出版日 ページ情報 英文 160 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.01円で換算しております。
Back to Top
骨成長刺激製品の世界市場の予測 〜2022年:製品 (各種装置・骨形成タンパク質・多血小板血漿)・用途・エンドユーザー別 Bone Growth Stimulator Market by Product (Device, Boner Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022
出版日: 2017年05月04日 ページ情報: 英文 160 Pages
概要

世界の骨成長刺激製品の市場は予測期間中、5.4%のCAGR (年間複合成長率) で推移し、2022年には14億1000万米ドルの規模に成長すると予測されています。非侵襲性・最小侵襲性外科手術を希望する患者の増加、対象患者数の増加、コスト効率、骨折治療において他の治療法を上回るメリットなどの要因が同市場の成長を推進しています。

当レポートでは、世界の骨成長刺激製品の市場を調査し、市場の定義と概要、サプライチェーン、市場成長への各種影響因子および市場機会の分析、製品・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

FIGURE 16 BONE GROWTH STIMULATOR MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要:推移と予測
  • 地域分析:タイプ別
  • 市場実績・予測:用途別
  • 市場実績・予測:エンドユーザー別
  • 成長機会・展望:地域別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 産業動向

  • イントロダクション
  • 主な産業動向
  • サプライチェーン
  • ポーターのファイブフォース分析

第7章 市場分析:製品別

  • イントロダクション
  • 骨成長刺激装置
    • 外部骨成長刺激装置
      • パルス電磁場デバイス
      • 容量性カップリングデバイス
      • 複合電磁場デバイス
    • インプラント骨成長刺激装置
    • 超音波骨成長刺激装置
  • 骨形成タンパク質
  • 多血小板血漿

第8章 市場分析:用途別

  • イントロダクション
  • 外科的脊椎固定
  • 癒合遅延・偽関節
  • 口腔・顎顔面外科
  • その他

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 在宅ケア
  • 学術&研究機関・CRO

第10章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他の地域

第11章 競合環境

  • イントロダクション
  • VENDOR DIVE:概要
  • 主要企業の製品ポートフォリオ
  • 主要企業の事業戦略

第12章 企業プロファイル

  • 主要企業
    • ORTHOFIX INTERNATIONAL N.V.
    • DJO FINANCE LLC
    • ZIMMER BIOMET HOLDINGS, INC.
    • BIOVENTUS LLC
    • MEDTRONIC PLC
    • STRYKER CORPORATION
    • DEPUY SYNTHES
    • ARTHREX, INC.
    • ISTO BIOLOGICS
    • HARVEST TECHNOLOGIES
  • 新興企業
    • OSSATEC BENELUX LTD.
    • EMBER THERAPEUTICS INC.
    • REGEN LAB SA
    • ALTIS BIOLOGICS (PTY) LTD.
    • ITO CO., LTD.

第13章 付録

目次
Product Code: MD 5234

The global bone growth stimulators market is estimated to reach USD 1.41 billion by 2022, growing at a CAGR of 5.4% during the forecast period. The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population (including rising aging population and prevalence of obesity and diabetes) and cost-effectiveness and advantage of bone stimulation devices in bone fracture treatments over other alternative treatment options are some key factors propelling the growth of this market.

In this report, the market has been segmented on the basis of product, end user, application, and region. On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, dental and maxillofacial surgeries, and other applications. In 2016, the spinal fusion surgeries segment accounted for the largest share of the market. This growth can be attributed to the established safety and efficacy of stimulators in fusion surgery, rising patient cases related to bone fracture, and growing number of spine procedures performed across the globe.

Geographically, North America commanded the largest share of the global bone growth stimulators market in 2016, followed by Europe. The growing elderly population, increasing incidence of arthritis and sports-related injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries are some of the major factors driving the demand for bone growth stimulators in North America.

Report Coverage:

This report studies the global bone growth stimulators market based on product, application, and end user. The report also studies, factors (such as drivers, restraints, opportunities, and challenges) which affect market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the bone growth stimulators market.

Reasons to Buy the Report:

From an insights perspective, this research report is focused on various levels of analysis-industry trends and company profiles-which together discuss basic views on the competitive landscape, emerging, and high growth segments of the bone growth stimulators market, and high growth regions and their respective drivers, restraints, opportunities, and challenges.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the bone growth stimulators market. The report analyzes the market based on product, application, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the bone growth stimulators market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bone growth stimulators across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bone growth stimulators market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the bone growth stimulators market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. OPPORTUNITY INDICATORS
      • 2.4.1.1. Rapid growth in the geriatric population
      • 2.4.1.2. Healthcare expenditure patterns
      • 2.4.1.3. Significant number of road accidents
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BONE GROWTH STIMULATOR: MARKET SNAPSHOT (2017-2022)
  • 4.2. GEOGRAPHIC ANALYSIS: BONE GROWTH STIMULATOR MARKET, BY TYPE (2017)
  • 4.3. GLOBAL BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2017 VS. 2022)
  • 4.4. GLOBAL BONE GROWTH STIMULATOR MARKET SIZE, BY END USER (2017 VS. 2022)
  • 4.5. BONE GROWTH STIMULATOR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES TILL 2022

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MAJOR MARKET DRIVERS
      • 5.2.1.1. Growing patient preference for noninvasive and minimally invasive surgical treatments
      • 5.2.1.2. Increasing target patient population
      • 5.2.1.3. Procedural benefits offered by bone stimulation devices in bone fracture treatment
    • 5.2.2. MAJOR MARKET RESTRAINTS
      • 5.2.2.1. Limited medical reimbursement for bone stimulation products
      • 5.2.2.2. High treatment costs associated with BMP and PRP products
    • 5.2.3. MAJOR MARKET OPPORTUNITIES
      • 5.2.3.1. Emerging markets
    • 5.2.4. MAJOR MARKET CHALLENGES
      • 5.2.4.1. Lawsuits filed against major market players affecting the brand value
      • 5.2.4.2. Side effects associated with BMP-based orthopedic treatment

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. KEY INDUSTRY TRENDS
    • 6.2.1. OFF-LABEL USE OF BMP PRODUCTS
    • 6.2.2. INCREASING USE OF PRP IN OTHER APPLICATIONS
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS

7. GLOBAL BONE GROWTH STIMULATOR MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. BONE GROWTH STIMULATION DEVICES
    • 7.2.1. EXTERNAL BONE GROWTH STIMULATORS
      • 7.2.1.1. Pulsed electromagnetic field devices
      • 7.2.1.2. Capacitive coupling devices
      • 7.2.1.3. Combined magnetic field devices
    • 7.2.2. IMPLANTED BONE GROWTH STIMULATORS
    • 7.2.3. ULTRASONIC BONE GROWTH STIMULATORS
  • 7.3. BONE MORPHOGENETIC PROTEINS
  • 7.4. PLATELET-RICH PLASMA

8. GLOBAL BONE GROWTH STIMULATOR MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. SPINAL FUSION SURGERIES
  • 8.3. DELAYED UNION & NONUNION BONE FRACTURES
  • 8.4. ORAL AND MAXILLOFACIAL SURGERIES
  • 8.5. OTHER APPLICATIONS

9. GLOBAL BONE GROWTH STIMULATOR MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS & CLINICS
  • 9.3. HOME CARE
  • 9.4. ACADEMIC & RESEARCH INSTITUTES AND CROS

10. GLOBAL BONE GROWTH STIMULATOR MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. VENDOR DIVE OVERVIEW
    • 11.2.1. VANGUARDS
    • 11.2.2. INNOVATORS
    • 11.2.3. DYNAMIC PLAYERS
    • 11.2.4. EMERGING PLAYERS
  • 11.3. ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN BGS MARKET (FOR 23 PLAYERS)
  • 11.4. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN BGS MARKET (FOR 23 PLAYERS)

Top 23 companies analyzed for this study are: Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), Harvest Technologies Corporation (U.S.), Ember Therapeutics, Inc. (U.S.), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), IGEA S.p.A (Italy), ITO CO., LTD. (Japan), Fintek Bo-electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (U.S.), Ivy Sports Medicine, LLC (U.S.), Glofinn Oy (Finland), and REM IGROUP (India).

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. TOP MARKET PLAYERS
    • 12.1.1. ORTHOFIX INTERNATIONAL N.V.
    • 12.1.2. DJO FINANCE LLC
    • 12.1.3. ZIMMER BIOMET HOLDINGS, INC.
    • 12.1.4. BIOVENTUS LLC
    • 12.1.5. MEDTRONIC PLC
    • 12.1.6. STRYKER CORPORATION
    • 12.1.7. DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON)
    • 12.1.8. ARTHREX, INC.
    • 12.1.9. ISTO BIOLOGICS
    • 12.1.10. HARVEST TECHNOLOGIES (A TERUMO BCT COMPANY)
  • 12.2. EMERGING MARKET PLAYERS
    • 12.2.1. OSSATEC BENELUX LTD.
    • 12.2.2. EMBER THERAPEUTICS INC.
    • 12.2.3. REGEN LAB SA
    • 12.2.4. ALTIS BIOLOGICS (PTY) LTD.
    • 12.2.5. ITO CO., LTD.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: GLOBAL BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: PEMF DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: CC DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: CMF DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: IMPLANTED BONE GROWTH STIMULATOR MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: ULTRASONIC BONE GROWTH STIMULATOR MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: PLATELET-RICH PLASMA MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 14: BONE GROWTH STIMULATOR MARKET SIZE FOR SPINAL FUSION SURGERIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: BONE GROWTH STIMULATOR MARKET SIZE FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: BONE GROWTH STIMULATOR MARKET SIZE FOR ORAL AND MAXILLOFACIAL SURGERIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: BONE GROWTH STIMULATOR MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE FOR HOME CARE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES AND CROS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: GLOBAL BONE GROWTH STIMULATOR MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: BONE GROWTH STIMULATOR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BONE GROWTH STIMULATOR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: BONE GROWTH STIMULATOR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 30: U.S.: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 31: U.S.: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 34: EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: GERMANY: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 41: GERMANY: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: U.K.: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 43: U.K.: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: FRANCE: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 45: FRANCE: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 46: REST OF EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: REST OF EUROPE: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: BONE GROWTH STIMULATOR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: BONE GROWTH STIMULATOR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 54: JAPAN: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 55: JAPAN: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: CHINA: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 57: CHINA: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: INDIA: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 59: INDIA: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: ROAPAC: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: ROAPAC: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 62: ROW: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: ROW: BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ROW: EXTERNAL BONE GROWTH STIMULATOR MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ROW: BONE GROWTH STIMULATOR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL BONE GROWTH STIMULATOR MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: RESEARCH METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION)
  • FIGURE 7: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000-2014
  • FIGURE 8: HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2000-2014
  • FIGURE 9: NUMBER OF ROAD ACCIDENTS WORLDWIDE, 2010 VS. 2014
  • FIGURE 10: DATA TRIANGULATION METHODOLOGY
  • FIGURE 11: BONE GROWTH STIMULATOR MARKET SIZE, BY PRODUCT (2017 VS. 2022)
  • FIGURE 12: BONE GROWTH STIMULATION DEVICES MARKET SIZE, BY TYPE (2017 VS. 2022)
  • FIGURE 13: BONE GROWTH STIMULATOR MARKET SHARE, BY END USER (2017 VS. 2022)
  • FIGURE 14: BONE GROWTH STIMULATOR MARKET SIZE, BY APPLICATION (2017 VS. 2022)
  • FIGURE 15: BONE GROWTH STIMULATOR MARKET SHARE, BY REGION (2016)
  • FIGURE 16: INCREASING TARGET PATIENT POPULATION-PRIMARY GROWTH DRIVER OF THE BONE GROWTH STIMULATOR MARKET
  • FIGURE 17: U.S. COMMANDED THE LARGEST SHARE OF THE BONE GROWTH STIMULATOR MARKET IN 2017
  • FIGURE 18: SPINAL FUSION SURGERIES SEGMENT WILL CONTINUE TO DOMINATE THE BONE GROWTH STIMULATOR MARKET IN 2022
  • FIGURE 19: HOSPITALS & CLINICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL BONE GROWTH STIMULATOR MARKET IN 2017
  • FIGURE 20: INDIA AND CHINA ARE LUCRATIVE MARKETS FOR MANUFACTURERS OF BONE GROWTH STIMULATORS
  • FIGURE 21: SUPPLY CHAIN ANALYSIS: BONE GROWTH STIMULATORS INDUSTRY (2016)
  • FIGURE 22: BONE GROWTH STIMULATOR MARKET: PORTER'S FIVE FORCES ANALYSIS (2016)
  • FIGURE 23: PRP, THE FASTEST-GROWING SEGMENT OF THE GLOBAL BONE GROWTH STIMULATOR MARKET
  • FIGURE 24: SPINAL FUSION SURGERIES, THE FASTEST-GROWING APPLICATION SEGMENT OF THE GLOBAL BONE GROWTH STIMULATOR MARKET
  • FIGURE 25: HOSPITALS & CLINICS TO BE THE FASTEST-GROWING END-USER SEGMENT IN THE GLOBAL BONE GROWTH STIMULATOR MARKET
  • FIGURE 26: ASIA-PACIFIC TO OFFER HIGH GROWTH POTENTIAL IN THE GLOBAL BONE GROWTH STIMULATOR MARKET TILL 2022
  • FIGURE 27: NORTH AMERICA: BONE GROWTH STIMULATOR MARKET SNAPSHOT
  • FIGURE 28: EUROPE: BONE GROWTH STIMULATOR MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: BONE GROWTH STIMULATOR MARKET SNAPSHOT
  • FIGURE 30: MNM DIVE - VENDOR COMPARISON MATRIX: BONE GROWTH STIMULATOR
  • FIGURE 31: ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT (2015)
  • FIGURE 32: ORTHOFIX INTERNATIONAL N.V.: PRODUCT OFFERING SCORECARD
  • FIGURE 33: ORTHOFIX INTERNATIONAL N.V.: BUSINESS STRATEGY SCORECARD
  • FIGURE 34: DJO FINANCE LLC: COMPANY SNAPSHOT (2015)
  • FIGURE 35: DJO FINANCE LLC: PRODUCT OFFERING SCORECARD
  • FIGURE 36: DJO FINANCE LLC : BUSINESS STRATEGY SCORECARD
  • FIGURE 37: ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 38: ZIMMER BIOMET HOLDINGS, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 39: ZIMMER BIOMET HOLDINGS, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 40: BIOVENTUS LLC: PRODUCT OFFERING SCORECARD
  • FIGURE 41: BIOVENTUS LLC: BUSINESS STRATEGY SCORECARD
  • FIGURE 42: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 43: MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
  • FIGURE 44: MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
  • FIGURE 45: STRYKER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 46: STRYKER CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 47: STRYKER CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 48: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2016)
  • FIGURE 49: JOHNSON & JOHNSON: PRODUCT OFFERING SCORECARD
  • FIGURE 50: JOHNSON & JOHNSON: BUSINESS STRATEGY SCORECARD
  • FIGURE 51: ARTHREX, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 52: ARTHREX, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 53: ISTO BIOLOGICS: PRODUCT OFFERING SCORECARD
  • FIGURE 54: ISTO BIOLOGICS: BUSINESS STRATEGY SCORECARD
  • FIGURE 55: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 56: TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 57: TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 58: OSSATEC BENELUX LTD.: PRODUCT OFFERING SCORECARD
  • FIGURE 59: OSSATEC BENELUX LTD.: BUSINESS STRATEGY SCORECARD
  • FIGURE 60: EMBER THERAPEUTICS, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 61: EMBER THERAPEUTICS, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 62: REGEN LAB SA: PRODUCT OFFERING SCORECARD
  • FIGURE 63: REGEN LAB SA: BUSINESS STRATEGY SCORECARD
  • FIGURE 64: ALTIS BIOLOGICS (PTY) LTD.: PRODUCT OFFERING SCORECARD
  • FIGURE 65: ALTIS BIOLOGICS (PTY) LTD.: BUSINESS STRATEGY SCORECARD
  • FIGURE 66: ITO CO., LTD: PRODUCT OFFERING SCORECARD
  • FIGURE 67: ITO CO., LTD: BUSINESS STRATEGY SCORECARD
Back to Top